Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 10, Pages 2305
Publisher
MDPI AG
Online
2021-05-12
DOI
10.3390/cancers13102305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer
- (2021) Yetirajam Rajesh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Another Weapon against Cancer and Metastasis: Physical-Activity-Dependent Effects on Adiposity and Adipokines
- (2021) Silvia Perego et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease
- (2021) María Arechederra et al. Cancers
- The Clinical Role of Serum Epidermal Growth Factor Receptor 3 in Hepatitis C Virus-Infected Patients with Early Hepatocellular Carcinoma
- (2021) Gian Paolo Caviglia et al. Biology-Basel
- The combination of PIVKA‐II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long‐term oral therapy
- (2020) Alessandro Loglio et al. LIVER INTERNATIONAL
- Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
- (2020) Tudor Mocan et al. Journal of Clinical Medicine
- Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
- (2020) Federico Piñero et al. Cells
- Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma
- (2020) Gabriele Ricco et al. Cancer Biomarkers
- Novel Calculators for Risk Stratification in Hepatocellular Carcinoma
- (2020) Mario Pirisi et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
- (2020) Rong Fan et al. JOURNAL OF HEPATOLOGY
- Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
- (2020) Yoshio Sumida et al. Diagnostics
- Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
- (2020) Daniel Q. Huang et al. Nature Reviews Gastroenterology & Hepatology
- Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives
- (2020) Yasi Pan et al. Biomedicines
- Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
- (2020) Cristiana Bianco et al. JOURNAL OF HEPATOLOGY
- Non-invasive biomarkers for the detection of hepatocellular carcinoma
- (2019) Daniela Campion et al. MINERVA BIOTECNOLOGICA
- Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
- (2019) Tatsuo Kanda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
- (2019) Hannah K. Drescher et al. Cells
- Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma
- (2019) Kazuki Takakura et al. Frontiers in Oncology
- GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
- (2019) Jan Best et al. Clinical Gastroenterology and Hepatology
- Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma
- (2019) Lokau et al. Cancers
- Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers
- (2018) Gabriele Ricco et al. Cancer Biomarkers
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease
- (2018) Marie Boyle et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis
- (2018) Gian Paolo Caviglia et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options
- (2018) Zobair Younossi et al. JOURNAL OF HEPATOLOGY
- Performance of Serum Glypican 3 in Diagnosis of Hepatocellular Carcinoma: A meta-analysis
- (2018) Dahai Xu et al. Annals of Hepatology
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
- (2016) Andrea Marengo et al. Annual Review of Medicine
- Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma
- (2016) Mohammed M.H. Al-Gayyar et al. BIOLOGICAL CHEMISTRY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Highly sensitive alpha-fetoprotein,Lens culinarisagglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection
- (2015) Gian Paolo Caviglia et al. HEPATOLOGY RESEARCH
- Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients
- (2015) Hayato Nakagawa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data
- (2015) Silvia Gaia et al. LIVER INTERNATIONAL
- Serum adiponectin levels may be associated with the pathogenesis of hepatocellular carcinoma
- (2014) Rong-Rong Song et al. TUMOR BIOLOGY
- The Detection of Hepatocellular Carcinoma Using a Prospectively Developed and Validated Model Based on Serological Biomarkers
- (2013) P. J. Johnson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
- (2010) Eek Joong Park et al. CELL
- Suppression of Liver Tumor Growth and Metastasis by Adiponectin in Nude Mice through Inhibition of Tumor Angiogenesis and Downregulation of Rho Kinase/IFN-Inducible Protein 10/Matrix Metalloproteinase 9 Signaling
- (2010) K. Man et al. CLINICAL CANCER RESEARCH
- Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular Carcinoma
- (2010) Neeraj K. Saxena et al. GASTROENTEROLOGY
- Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients
- (2010) Toru Arano et al. INTERNATIONAL JOURNAL OF CANCER
- Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis
- (2009) A. SINGAL et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Alcoholic liver disease
- (2009) Robert S. O'Shea et al. HEPATOLOGY
- Adiponectin deficiency impairs liver regeneration through attenuating STAT3 phosphorylation in mice
- (2009) Run-Zhe Shu et al. LABORATORY INVESTIGATION
- AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
- (2008) Gary Beale et al. BMC CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started